A detailed review of 12 U.S. based synthetic biology, biofuel & biochemical companies that are developing third and fourth generation biofuels, bioindustrial & household chemical, and food additive products; using synthetic biology to produce engineered microorganisms and specialty enzymatic products. Each company is examined in turn, looking at its financials and the uniqueness and strength of its processes and technology as well as at any important partnerships or alliances that have been formed.
On August 11, the Financial Times reported on the promise of “synthetic biology,” including the development of algae that generates biofuels. In July, ExxonMobil entered into a $600 million venture with Synthetic Genomics, a firm founded by biotech pioneer Dr. Craig Venter. “Synthetic Genomics has already engineered strains of algae that secrete oil from their cells,” writes the FT’s Clive Cookson. Will oil companies transform themselves into algae companies? Or, a few years from now, could the makers of “Who Killed the Electric Car?” film a sequel about algae?